A Single Group Study to Evaluate the Effects of a Probiotic Supplement on Vaginal Health.

NCT ID: NCT06506357

Last Updated: 2024-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-24

Study Completion Date

2024-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This virtual single-group clinical trial aims to evaluate the effects of the Good Girl Probiotics supplement on vaginal health. Participants will take one capsule of the probiotic supplement daily for eight weeks. They will complete questionnaires at Baseline, after the first dose, and at the end of Weeks 2, 4, 6, and 8 to assess changes in vaginal pH, vaginal health, and urinary tract health.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaginal Health Women's Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic Supplement Group

Participants in this group will receive the Good Girl Probiotics supplement.

Group Type EXPERIMENTAL

Good Girl Probiotics

Intervention Type DIETARY_SUPPLEMENT

Participants will take one capsule of the Good Girl Probiotics supplement daily in the morning for eight weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Good Girl Probiotics

Participants will take one capsule of the Good Girl Probiotics supplement daily in the morning for eight weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female at birth.
* Aged 18+.
* Interested in supporting a balanced vaginal pH, vaginal health, and urinary tract health.
* Regularly experience symptoms of an unbalanced vagina, including an atypical smell, discharge, itching, swelling, irritation, pain during sex, and/or burning sensation while urinating.
* Willing to avoid using products or medications that target vaginal or urinary tract health infections.
* Willing to avoid other probiotics.
* Able to follow the study protocol.

Exclusion Criteria

* Two or more bladder infections in six months or three or more infections in a year.
* Recent surgeries or invasive treatments within the last six months.
* Use of products or medications targeting vaginal or urinary tract health in the last 12 weeks.
* Known allergies to the product ingredients.
* Chronic health conditions impacting participation.
* Pregnant, breastfeeding, or trying to conceive.
* History of substance abuse.
* Current or former smoker within the past six months.
* Participation in another clinical trial.
* Diagnosed vaginal or pelvic conditions.
* Use of vaginal-related birth control (NuvaRing, IUD).
* Changes in hormonal birth control in the last three months.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Citruslabs

INDUSTRY

Sponsor Role collaborator

Love Wellness

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Citruslabs

Santa Monica, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20433

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Probiotic Modulates Vaginal Microflora
NCT05302687 COMPLETED PHASE2/PHASE3
The Role of Probiotic LH76 in Human Gut Health
NCT06875375 NOT_YET_RECRUITING NA